EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Artificial Gametogenesis and In Vitro Spermatogenesis: Emerging Strategies for the Treatment of Male Infertility

Aris Kaltsas iD, Maria-Anna Kyrgiafini iD, Eleftheria Markou, Andreas Koumenis iD, Zissis Mamuris iD, Fotios Dimitriadis iD, Athanasios Zachariou iD, Michael Chrisofos, Nikolaos Sofikitis

International Journal of Molecular Sciences · 30.07.2025 · 26 (15) · 7383

DOI: 10.3390/ijms26157383 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.07.2025. Verfasst von Aris Kaltsas und 8 weiteren Autor:innen. Beteiligte Einrichtung: Third Department of Urology, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece. Hauptthemen laut MEDLINE: Spermatogenesis, Infertility, Male, Gametogenesis. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Male-factor infertility accounts for approxiamately half of all infertility cases globally, yet therapeutic options remain limited for individuals with no retrievable spermatozoa, such as those with non-obstructive azoospermia (NOA). In recent years, artificial gametogenesis has emerged as a promising avenue for fertility restoration, driven by advances in two complementary strategies: organotypic in vitro spermatogenesis (IVS), which aims to complete spermatogenesis ex vivo using native testicular tissue, and in vitro gametogenesis (IVG), which seeks to generate male gametes de novo from pluripotent or reprogrammed somatic stem cells. To evaluate the current landscape and future potential of these approaches, a narrative, semi-systematic literature search was conducted in PubMed and Scopus for the period January 2010 to February 2025. Additionally, landmark studies published prior to 2010 that contributed foundational knowledge in spermatogenesis and testicular tissue modeling were reviewed to provide historical context. This narrative review synthesizes multidisciplinary evidence from cell biology, tissue engineering, and translational medicine to benchmark IVS and IVG technologies against species-specific developmental milestones, ranging from rodent models to non-human primates and emerging human systems. Key challenges—such as the reconstitution of the blood–testis barrier, stage-specific endocrine signaling, and epigenetic reprogramming—are discussed alongside critical performance metrics of various platforms, including air–liquid interface slice cultures, three-dimensional organoids, microfluidic “testis-on-chip” devices, and stem cell-derived gametogenic protocols. Particular attention is given to clinical applicability in contexts such as NOA, oncofertility preservation in prepubertal patients, genetic syndromes, and reprocutive scenarios involving same-sex or unpartnered individuals. Safety, regulatory, and ethical considerations are critically appraised, and a translational framework is outlined that emphasizes biomimetic scaffold design, multi-omics-guided media optimization, and rigorous genomic and epigenomic quality control. While the generation of functionally mature sperm in vitro remains unachieved, converging progress in animal models and early human systems suggests that clinically revelant IVS and IVG applications are approaching feasibility, offering a paradigm shift in reproductive medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SpermatogenesisInfertility, MaleGametogenesisHumansMaleAnimalsTissue EngineeringTestis

Stichwörter der Autor:innen

ethical considerationsin vitro gametogenesisin vitro spermatogenesismale infertilityorganoidspluripotent stem cells

Autor:innen und Institutionen

  • Third Department of Urology, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece.
  • Laboratory of Genetics, Comparative and Evolutionary Biology, Department of Biochemistry and Biotechnology, University of Thessaly, Viopolis, Mezourlo, 41500 Larissa, Greece.
  • Department of Microbiology, University Hospital of Ioannina, 45500 Ioannina, Greece.
  • Department of Urology, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
  • Laboratory of Spermatology, Department of Urology, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece.

ORCID-Profile: Aris Kaltsas, Maria-Anna Kyrgiafini, Andreas Koumenis, Zissis Mamuris, Fotios Dimitriadis, Athanasios Zachariou

Zitieren

APA

Kaltsas, A., Kyrgiafini, M. A., Markou, E., Koumenis, A., Mamuris, Z., Dimitriadis, F., Zachariou, A., Chrisofos, M., & Sofikitis, N. (2025). Artificial Gametogenesis and In Vitro Spermatogenesis: Emerging Strategies for the Treatment of Male Infertility. International Journal of Molecular Sciences, 26(15), 7383. https://doi.org/10.3390/ijms26157383

Vancouver

Kaltsas A, Kyrgiafini MA, Markou E, Koumenis A, Mamuris Z, Dimitriadis F, et al. Artificial Gametogenesis and In Vitro Spermatogenesis: Emerging Strategies for the Treatment of Male Infertility. International Journal of Molecular Sciences. 2025;26(15):7383. doi:10.3390/ijms26157383

BibTeX
@article{Kaltsas2025,
  author = {Kaltsas, Aris and Kyrgiafini, Maria-Anna and Markou, Eleftheria and Koumenis, Andreas and Mamuris, Zissis and Dimitriadis, Fotios and Zachariou, Athanasios and Chrisofos, Michael and Sofikitis, Nikolaos},
  title = {Artificial Gametogenesis and In Vitro Spermatogenesis: Emerging Strategies for the Treatment of Male Infertility},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {15},
  pages = {7383},
  doi = {10.3390/ijms26157383}
}
Kostenlos starten →